Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Bioactivation and Regioselectivity of Pig Cytochrome P450 3A29 towards Aflatoxin B₁.

Wu J, Chen R, Zhang C, Li K, Xu W, Wang L, Chen Q, Mu P, Jiang J, Wen J, Deng Y.

Toxins (Basel). 2016 Sep 12;8(9). pii: E267. doi: 10.3390/toxins8090267.

2.

Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.

Singh M, Kapoor A, Bhatnagar A.

Chem Biol Interact. 2015 Jun 5;234:261-73. doi: 10.1016/j.cbi.2014.12.028.

3.

Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.

Shultz CA, Quinn AM, Park JH, Harvey RG, Bolton JL, Maser E, Penning TM.

Chem Res Toxicol. 2011 Dec 19;24(12):2153-66. doi: 10.1021/tx200294c.

4.

Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Roebuck BD, Johnson DN, Sutter CH, Egner PA, Scholl PF, Friesen MD, Baumgartner KJ, Ware NM, Bodreddigari S, Groopman JD, Kensler TW, Sutter TR.

Toxicol Sci. 2009 May;109(1):41-9. doi: 10.1093/toxsci/kfp003.

5.

The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Barski OA, Tipparaju SM, Bhatnagar A.

Drug Metab Rev. 2008;40(4):553-624. doi: 10.1080/03602530802431439 . Review.

6.

Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.

Bodreddigari S, Jones LK, Egner PA, Groopman JD, Sutter CH, Roebuck BD, Guengerich FP, Kensler TW, Sutter TR.

Chem Res Toxicol. 2008 May;21(5):1134-42. doi: 10.1021/tx7004458.

7.

Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Penning TM, Drury JE.

Arch Biochem Biophys. 2007 Aug 15;464(2):241-50. Review.

Supplemental Content

Support Center